Ken Pittman

843 citations
23 papers · 285 · h-index 9

Impact in

Papers in

    • Cancer Treatment and Pharmacology 3
    • Cancer Diagnosis and Treatment 3
    • HER2/EGFR in Cancer Research 3
    • Colorectal Cancer Treatments and Studies 3
    • Peptidase Inhibition and Analysis 2

Ken Pittman

23 papers receiving 275 citations

Peers

Ken Pittman
Comparison fields: 5 of 66
  • Clinical Biochemistry 36
  • Oncology 110
  • Oral Surgery 16
  • Pathology and Forensic Medicine 27
  • Pediatrics, Perinatology and Child Health 25
Replace Yanyan He with:
Yanyan He China
Antonieta Solar Chile
R Floris Italy
Vahit Yükselen Türkiye
Sun Jin Park South Korea
Yumiko Inui Japan
Yoshitaka Koshino Japan
Mitra Naseri Iran
Taro Kubo Japan
Leo Francis Australia
Ken Pittman relative to Yanyan He China Yanyan He's profile →
Citations per field
00.5×6.3×
Yanyan He · 1×
Citations per year

Countries citing papers authored by Ken Pittman

Since Specialization
Citations

This map shows the geographic impact of Ken Pittman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Pittman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Pittman more than expected).

Fields of papers citing papers by Ken Pittman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Pittman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Pittman. The network helps show where Ken Pittman may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken Pittman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Pittman Line = papers co-authored together Ken Pittman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200784
2 200633
3 200831
4 201021
5 199419
6 201417
7
Epidemiology of cancers of the kidney in an Australian population.
201114
8 20089
9 20179
10 20098
11 19927
12 19996
13 20066
14 20156
15 20113
16 20073
17 20072
18 20082
19 20091
20 20091

About Ken Pittman

Ken Pittman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Pathology and Forensic Medicine and Neurology, having authored 23 papers that have together received 285 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Cancer Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Oral and Maxillofacial Pathology (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Peptidase Inhibition and Analysis (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (36 citations), Oncology (110 citations), Oral Surgery (16 citations), Pathology and Forensic Medicine (27 citations) and Pediatrics, Perinatology and Child Health (25 citations). Ken Pittman has collaborated with scholars based in Australia, United Kingdom and Barbados. Frequent co-authors include Timothy Price, Janice Fletcher, Louise Nott, Peter J. Selby, Colin Luke, Christos S. Karapetis, Dusan Kotasek, W. K. Patterson, Bogda Koczwara and David Roder. Their work appears in journals such as Journal of Clinical Oncology, Critical Reviews in Oncology/Hematology, Australian and New Zealand Journal of Public Health, Journal of Clinical Gastroenterology and Journal of Evaluation in Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact